1.	Phase III Double Blind, Placebo Controlled, Randomized Study of the Effectiveness of Pentoxifylline in Maintaining Weight in Patients Undergoing Chemotherapy for Metastatic Cancer (Summary Last Modified 07/98) Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: URCC-U2994, URCC-2994PM, NCI-P97-0087
2.	Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000069218, NCCTG-989255, CAN-NCIC-SC18, NCI-P02-0205, SC18, NCT00031707
3.	Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: Adult Sponsor: NCI, Other Protocol IDs: CDR0000069417, NCCTG-N01C9, NCI-P02-0226, N01C9, NCT00040885
4.	Phase III Randomized Adjuvant Preoperative Total Parenteral Nutrition in Patients Undergoing Surgery for Carcinoma of the Esophagus, Stomach, Pancreas, Colon, and Rectum Phase: Phase III Type: Supportive care Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: NCI-83-C-103, NCI-T83-1089N, T83-1089
5.	Phase III Double-Blind Randomized Study of CACP/VBL plus Hydrazine Sulfate vs Placebo in Patients with Advanced non-Small Cell Lung Cancer Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: CLB-8931, CALGB-8931
6.	Phase III Randomized Comparison of Hydrazine Sulfate vs Placebo in Patients with Advanced non-Small Cell Lung Cancer Receiving CACP/VP-16 Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: over 18 Sponsor: NCI Protocol IDs: NCCTG-892451, NCCTG-89-24-51
7.	Phase III Randomized Double-Blind Comparison of Anticachectic Therapy with Hydrazine Sulfate vs Placebo in Patients with Advanced 5-FU-Resistant Colorectal Cancer and a Randomized Comparison of Quality-of-Life Assessment Tools Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-894951, MAYO-894951, NCCTG-89-49-51
8.	Phase III Randomized Study of Megestrol Acetate vs Fluoxymesterone vs Dexamethasone for the Treatment of Cancer-Related and Cancer Treatment-Related Anorexia and Cachexia Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-919252, MAYO-919252, NCI-P92-0004
9.	Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000257027, NCCTG-N00C1, NCI-P02-0232, MC00C8, 1497-00, N00C1, NCT00046904
10.	Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer Phase: Phase III Type: Supportive care Status: Completed Age: 17 and over Sponsor: NCI, Other Protocol IDs: CDR0000269100, RTOG-0122, NCT00053053
11.	Creatine in Treating Patients With Cancer-Associated Weight Loss Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000360798, NCCTG-N02C4, N02C4, NCT00081250
12.	Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer Phase: Phase III Type: Supportive care Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000068329, CCCWFU-97300, CCCWFU-0009, CCCWFU-BG00-228, NCI-P00-0174, NCT00006799
13.	Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000069226, CCCWFU-98199, NCI-P02-0210, NCT00031785
14.	Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss Phase: Phase II, Phase I Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000065766, CLB-9473, NCI-P97-0097, CALGB-9473, NCT00003077
15.	Phase II Randomized Pilot Study of Pentoxifylline vs Placebo for Anorexia and Cachexia in Patients with Metastatic Malignancies (Summary Last Modified 03/98) Phase: Phase II Type: Supportive care Status: Closed Age: adult Sponsor: NCI Protocol IDs: SWOG-9327, NCI-P94-0058
16.	Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss Phase: Phase II Type: Supportive care Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: NU FDA98CC6, NU-98CC6, NCI-G00-1705, NCT00004912
17.	Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment Phase: Phase II Type: Supportive care Status: Completed Age: 2 to 20 Sponsor: NCI, Other Protocol IDs: SCUSF 0205, HLMCC-0205, U10CA081920, MCC-0205, NCT00066248
18.	Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000068522, DMS-0005, ATP-DMS-0005, NCI-G01-1923, NCT00014248
19.	Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: LCCC 0523, CDR0000549772, UNC-LCCC-0523, NCT00486304
20.	Randomized Study of Megestrol as an Appetite Stimulant in Children With Cancer-Related Cachexia (Summary Last Modified 02/2002) Phase: No phase specified Type: Supportive care Status: Completed Age: Under 21 Sponsor: NCI Protocol IDs: MCC-0004, NCI-3990, NCI-P02-0202
21.	Placebo-Controlled Evaluation of Megestrol Acetate in the Treatment of Cancer-Related Anorexia and Cachexia Phase: No phase specified Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-889251, MAYO-889251
22.	Dose-Response Evaluation of Megestrol to Treat Anorexia and Cachexia in Patients with Cancer Phase: No phase specified Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-899255, MAYO-899255, NCI-P90-0009
23.	Dose-Response Evaluation of Megestrol to Treat Cachexia in Patients with Advanced Lung or Colorectal Cancer (Summary Last Modified 12/92) Phase: No phase specified Type: Supportive care Status: Closed Age: over 16 Sponsor: NCI Protocol IDs: CLB-8971, NCI-P90-0012